JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Significant Increase in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 477,000 shares, an increase of 16.7% from the November 15th total of 408,600 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

OTCMKTS:JCRRF opened at $4.57 on Friday. JCR Pharmaceuticals has a fifty-two week low of $4.30 and a fifty-two week high of $4.70. The company has a fifty day moving average of $4.57 and a two-hundred day moving average of $4.70.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.